329 related articles for article (PubMed ID: 30265306)
1. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial.
Saunders H; Khan C; D'Hooghe T; Magnúsdóttir TB; Klingmann I; Hrafnsdóttir S;
Hum Reprod; 2020 Feb; 35(2):355-363. PubMed ID: 32074281
[TBL] [Abstract][Full Text] [Related]
3. Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.
Loreti S; Thiele K; De Brucker M; Olsen C; Centelles-Lodeiro J; Bourgain C; Waelput W; Tournaye H; Griesinger G; Raes J; Vieira-Silva S; Arck P; Blockeel C; Mackens S
Hum Reprod; 2024 Feb; 39(2):403-412. PubMed ID: 38110714
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.
Schütt B; Kaiser A; Schultze-Mosgau MH; Seitz C; Bell D; Koch M; Rohde B
Hum Reprod; 2016 Aug; 31(8):1703-12. PubMed ID: 27288475
[TBL] [Abstract][Full Text] [Related]
5. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.
Baker VL; Jones CA; Doody K; Foulk R; Yee B; Adamson GD; Cometti B; DeVane G; Hubert G; Trevisan S; Hoehler F; Jones C; Soules M
Hum Reprod; 2014 Oct; 29(10):2212-20. PubMed ID: 25100106
[TBL] [Abstract][Full Text] [Related]
7. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
[TBL] [Abstract][Full Text] [Related]
8. Effect of randomized serum progesterone concentration on secretory endometrial histologic development and gene expression.
Young SL; Savaris RF; Lessey BA; Sharkey AM; Balthazar U; Zaino RJ; Sherwin RA; Fritz MA
Hum Reprod; 2017 Sep; 32(9):1903-1914. PubMed ID: 28854727
[TBL] [Abstract][Full Text] [Related]
9. Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects.
Blake EJ; Norris PM; Dorfman SF; Longstreth J; Yankov VI
Fertil Steril; 2010 Sep; 94(4):1296-1301. PubMed ID: 19608168
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
11. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study.
Lewin A; Pisov G; Turgeman R; Fatum M; Shufaro Y; Simon A; Laufer N; Revel A; Reubinoff B; Safran A
Gynecol Endocrinol; 2002 Apr; 16(2):131-6. PubMed ID: 12012623
[TBL] [Abstract][Full Text] [Related]
12. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women.
Ross D; Cooper AJ; Pryse-Davies J; Bergeron C; Collins WP; Whitehead MI
Am J Obstet Gynecol; 1997 Oct; 177(4):937-41. PubMed ID: 9369848
[TBL] [Abstract][Full Text] [Related]
14. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts.
Shapiro DB; Pappadakis JA; Ellsworth NM; Hait HI; Nagy ZP
Hum Reprod; 2014 Aug; 29(8):1706-11. PubMed ID: 24847018
[TBL] [Abstract][Full Text] [Related]
15. Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women.
Pasquale SA; Foldesy RG; Levine JP; Bachmann GA; Blackwell RE
Fertil Steril; 1997 Nov; 68(5):810-5. PubMed ID: 9389807
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.
Schultze-Mosgau MH; Waellnitz K; Nave R; Klein S; Kraetzschmar J; Rautenberg T; Schmitz H; Rohde B
Hum Reprod; 2016 Aug; 31(8):1713-22. PubMed ID: 27390369
[TBL] [Abstract][Full Text] [Related]
17. Disturbances of the endometrium in the luteal phase of cycles stimulated for in vitro fertilization and of normal cycles treated with vaginal progesterone.
Kresanov I; Nikkanen V; Klemi P
Ann Chir Gynaecol Suppl; 1994; 208():33-9. PubMed ID: 8092768
[TBL] [Abstract][Full Text] [Related]
18. Analysis of serum and endometrial progesterone in determining endometrial receptivity.
Labarta E; Sebastian-Leon P; Devesa-Peiro A; Celada P; Vidal C; Giles J; Rodriguez-Varela C; Bosch E; Diaz-Gimeno P
Hum Reprod; 2021 Oct; 36(11):2861-2870. PubMed ID: 34382075
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
Bergh C; Lindenberg S;
Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
[TBL] [Abstract][Full Text] [Related]
20. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments.
Tavaniotou A; Smitz J; Bourgain C; Devroey P
Hum Reprod Update; 2000; 6(2):139-48. PubMed ID: 10782572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
